Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB26FY2Q9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,237
Award facts
- Contract value 100% obligated
- $5,237.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,237.24 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price, non-set-aside contract was executed on November 10, 2025, with an ultimate completion date of November 12, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels in patients with certain cardiovascular conditions, representing the type of specialty pharmaceutical that supports military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply an extensive range of medications, vaccines, medical devices, and healthcare commodities to support Defense Health Agency operations and other federal healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen has established itself through multiple competitively awarded contracts with DLA, demonstrating its capability to fulfill medical procurement requirements across diverse therapeutic domains for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FY2Q9?
SPE2DB26FY2Q9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FY2Q9 worth?
The government has obligated $5,237 on SPE2DB26FY2Q9.
Is contract SPE2DB26FY2Q9 an order under another contract?
Yes. SPE2DB26FY2Q9 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY2Q9 competed?
The extent of competition for SPE2DB26FY2Q9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award